{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T05:57:57Z","timestamp":1772431077833,"version":"3.50.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Autoantibodies against fibroblast growth factor receptor 3 (FGFR3) are associated with sensory neuropathy. In this report, we describe the case of a woman with a remote history of Hodgkin lymphoma in remission who presented with unilateral Adie pupil, trigeminal neuropathy, and progressive sensory neuropathy. After 3 years without a known etiology and slow progression of symptoms, a trial of intravenous immunoglobulin (IVIg) was initiated and she subsequently tested positive for anti-FGFR3 antibodies. Despite the delay in treatment, she showed significant improvement with maintenance monthly IVIg therapy. In addition to the case report, we provide a review of the literature on anti-FGFR3-positive sensory neuropathy. To our knowledge, this is the first report of Adie pupil in a patient with anti-FGFR3 antibodies.<\/jats:p>","DOI":"10.1097\/cnd.0000000000000545","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T05:00:25Z","timestamp":1772427625000},"page":"99-104","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["An Unusual Case of Anti-FGFR3 Antibodies, Sensory Neuropathy, and Adie Pupil in a Patient With Hodgkin Lymphoma in Remission and Review of the Literature"],"prefix":"10.1097","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2636-553X","authenticated-orcid":false,"given":"Sydney","family":"Peters","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wade","family":"Whitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis A","family":"Lizarraga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"R1-20260302","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1474-4422(05)70096-X","article-title":"Sensory neuron diseases","volume":"4","author":"Sghirlanzoni","year":"2005","journal-title":"Lancet Neurol"},{"key":"R2-20260302","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/jnnp-2019-321849","article-title":"Clinical characterisation of sensory neuropathy with anti-FGFR3 autoantibodies","volume":"91","author":"Tholance","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R3-20260302","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/mus.26748","article-title":"Cryptogenic small-fiber neuropathies: serum autoantibody binding to trisulfated heparan disaccharide and fibroblast growth factor receptor-3","volume":"61","author":"Levine","year":"2020","journal-title":"Muscle Nerve"},{"key":"R4-20260302","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.semcdb.2015.12.014","article-title":"Fibroblast growth factors, old kids on the new block","volume":"53","author":"Li","year":"2016","journal-title":"Semin Cell Dev Biol"},{"key":"R5-20260302","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1136\/jnnp-2014-309730","article-title":"Antifibroblast growth factor receptor 3 antibodies identify a subgroup of patients with sensory neuropathy","volume":"86","author":"Antoine","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R6-20260302","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1212\/WNL.98.18_supplement.1612","article-title":"Case series: a review of three patients with autonomic dysfunction and positive TS-HDS or FGFR3 antibodies (P17-1.006)","volume":"98","author":"Bourscheid","year":"2022","journal-title":"Neurology"},{"key":"R7-20260302","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1111\/ene.14180","article-title":"Clinical characteristics of fibroblast growth factor receptor 3 antibody-related polyneuropathy: a retrospective study","volume":"27","author":"Kovvuru","year":"2020","journal-title":"Eur J Neurol"},{"key":"R8-20260302","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12883-021-02090-2","article-title":"Clinical features with anti fibroblast growth factor receptor 3 (FGFR3) antibody-related polyneuropathy: a retrospective study","volume":"21","author":"Nagarajan","year":"2021","journal-title":"BMC Neurol"},{"key":"R9-20260302","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(00)03216-5","article-title":"Holmes-Adie syndrome","volume":"356","author":"Martinelli","year":"2000","journal-title":"Lancet (London, England)"},{"key":"R10-20260302","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.3389\/fneur.2019.01236","article-title":"Anti-Hu antibody-associated Adie's pupil and paraneoplastic sensorimotor polyneuropathy caused by primary mediastinal small cell carcinoma","volume":"10","author":"Zhang","year":"2019","journal-title":"Front Neurol"},{"key":"R11-20260302","doi-asserted-by":"crossref","first-page":"577757","DOI":"10.1016\/j.jneuroim.2021.577757","article-title":"Anti-FGFR3 antibody epitopes are functional sites and correlate with the neuropathy pattern","volume":"361","author":"Tholance","year":"2021","journal-title":"J Neuroimmunol"},{"key":"R12-20260302","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1056\/NEJMra2023935","article-title":"Sensory ganglionopathy","volume":"383","author":"Amato","year":"2020","journal-title":"N Engl J Med"},{"key":"R13-20260302","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/CND.0000000000000221","article-title":"FGFR3 antibodies in neuropathy: what to Do with them?","volume":"20","author":"Samara","year":"2018","journal-title":"J Clin Neuromuscul Dis"},{"key":"R14-20260302","doi-asserted-by":"crossref","first-page":"P2.433","DOI":"10.1212\/WNL.90.15_supplement.P2.433","article-title":"Use of intravenous immunoglobulin in small fiber neuropathy associated with FGFR3 (P2.433)","volume":"90","author":"Dave","year":"2018","journal-title":"Neurology"},{"key":"R15-20260302","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/mus.27745","article-title":"A double-blind placebo-controlled pilot study of immunoglobulin for small fiber neuropathy associated with TS-HDS and FGFR-3 autoantibodies","volume":"67","author":"Gibbons","year":"2023","journal-title":"Muscle Nerve"},{"key":"R16-20260302","doi-asserted-by":"crossref","first-page":"P1.455","DOI":"10.1212\/WNL.90.15_supplement.P1.455","article-title":"Clinical and electrodiagnostic findings in neuropathy with anti-fibroblast growth factor receptor 3 antibodies (P1.455)","volume":"90","author":"Boessen","year":"2018","journal-title":"Neurology"},{"key":"R17-20260302","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jns.2015.12.044","article-title":"Identifying a therapeutic window in acute and subacute inflammatory sensory neuronopathies","volume":"361","author":"Antoine","year":"2016","journal-title":"J Neurol Sci"},{"key":"R18-20260302","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/mus.27800","article-title":"IVIg for TS-HDS and FGFR-3 antibody\u2013positive small-fiber neuropathy: a fading signal for efficacy?","volume":"67","author":"Katzberg","year":"2023","journal-title":"Muscle Nerve"},{"key":"R19-20260302","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/jamaneurol.2020.0781","article-title":"Monitoring clinical course and treatment response in chronic inflammatory demyelinating polyneuropathy during routine care: a review of clinical and laboratory assessment measures","volume":"77","author":"Allen","year":"2020","journal-title":"JAMA Neurol"}],"container-title":["Journal of Clinical Neuromuscular Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CND.0000000000000545","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T05:00:28Z","timestamp":1772427628000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CND.0000000000000545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/cnd.0000000000000545","relation":{},"ISSN":["1522-0443","1537-1611"],"issn-type":[{"value":"1522-0443","type":"print"},{"value":"1537-1611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}